Literature DB >> 10731700

Purification of a 72-kDa protein-tyrosine kinase from rat liver and its identification as Syk: involvement of Syk in signaling events of hepatocytes.

S Tsuchida1, S Yanagi, R Inatome, J Ding, P Hermann, T Tsujimura, N Matsui, H Yamamura.   

Abstract

Syk protein-tyrosine kinase (PTK) has been implicated in a variety of hematopoietic cell responses including immunoreceptor signaling. However, so far, there has been no evidence of the expression of Syk or Syk-related PTK in non-hematopoietic tissues. In this study, we have purified from blood cell-depleted rat liver a 72-kDa cytoplasmic PTK which shows cross-reactivity with anti-Syk antibody. Partial amino acid sequence analysis revealed that this 72-kDa PTK is identical to Syk. Immunohistochemical and RT-PCR analyses demonstrated that Syk is expressed in human hepatocytes and two rat liver-derived cell lines, JTC-27 and RLC-16. Furthermore, Syk is significantly tyrosine-phosphorylated in response to angiotensin II in JTC-27 cells, and angiotensin II-induced MAP kinase activation is blocked by the treatment of cells with a Syk-selective inhibitor, piceatannol. These results suggest that Syk plays an important role in signaling events of hepatocytes, such as signaling steps leading to MAP kinase activation by G-protein-coupled receptors. This is the first report of the expression of Syk in non-hematopoietic tissue.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10731700     DOI: 10.1093/oxfordjournals.jbchem.a022610

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  8 in total

1.  Differential expression of spleen tyrosine kinase Syk isoforms in tissues: Effects of the microbial flora.

Authors:  Florentina Duta; Marina Ulanova; Daniel Seidel; Lakshmi Puttagunta; Sorin Musat-Marcu; Kevin S Harrod; Alan D Schreiber; Ulrich Steinhoff; A Dean Befus
Journal:  Histochem Cell Biol       Date:  2006-05-18       Impact factor: 4.304

2.  Downregulation of spleen tyrosine kinase in hepatocellular carcinoma by promoter CpG island hypermethylation and its potential role in carcinogenesis.

Authors:  So-Hyun Shin; Kwang Ho Lee; Baek-Hee Kim; Sun Lee; Hwan Seok Lee; Ja-June Jang; Gyeong Hoon Kang
Journal:  Lab Invest       Date:  2014-10-13       Impact factor: 5.662

3.  Human ezrin-moesin-radixin proteins modulate hepatitis C virus infection.

Authors:  Terence N Bukong; Karen Kodys; Gyongyi Szabo
Journal:  Hepatology       Date:  2013-09-17       Impact factor: 17.425

4.  Hypermethylation and prognostic implication of Syk gene in human colorectal cancer.

Authors:  Zuli Yang; Lijun Huo; Hao Chen; Beibei Ni; Jun Xiang; Liang Kang; Lei Wang; Junsheng Peng; Yunfei Yuan; Jianping Wang
Journal:  Med Oncol       Date:  2013-04-23       Impact factor: 3.064

Review 5.  Syk: a new player in the field of breast cancer.

Authors:  Z A Stewart; J A Pietenpol
Journal:  Breast Cancer Res       Date:  2000-11-02       Impact factor: 6.466

6.  SYK expression in human breast cancer.

Authors:  Ae Elkak; W Al Sarakbi; K Mokbel
Journal:  J Carcinog       Date:  2005-04-20

7.  Syk-Targeted, a New 3-Arylbenzofuran Derivative EAPP-2 Blocks Airway Inflammation of Asthma-COPD Overlap in vivo and in vitro.

Authors:  Shuyi Li; Yang Hui; Jiqiao Yuan; Ziqian Zhang; Xuyu Li; Nan Fang; Mingbao Lin; Qi Hou
Journal:  J Inflamm Res       Date:  2021-05-24

Review 8.  Role of spleen tyrosine kinase in liver diseases.

Authors:  Dhadhang Wahyu Kurniawan; Gert Storm; Jai Prakash; Ruchi Bansal
Journal:  World J Gastroenterol       Date:  2020-03-14       Impact factor: 5.742

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.